Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 64
Filter
1.
Colorectal Dis ; 22(4): 399-407, 2020 04.
Article in English | MEDLINE | ID: mdl-31698537

ABSTRACT

AIM: Preoperative factors predictive of permanent stoma creation were investigated in a long-term follow-up of patients with mid or low rectal cancer. METHOD: We included patients who underwent radical resection for mid or low rectal cancer with available data for preoperative anal function measured by manometry and Faecal Incontinence Severity Index questionnaire between January 2005 and December 2015 in three tertiary referral hospitals. A permanent stoma was defined as a stoma present until the patient's last follow-up visit or death. Preoperative factors that predicted permanent stoma creation were analysed. RESULTS: Over a median follow-up of 57.4 months (range 12-143 months), a permanent stoma was created in 144/577 (25.0%) patients, including 89 (15.4%) who underwent abdominoperineal resection, one (0.2%) who underwent Hartmann's operation without reversal, 15 (2.6%) with a diverting ileostomy at the time of initial sphincter-preserving surgery without undergoing stoma reversal, and 39 (6.8%) who underwent permanent ileostomy formation after sphincter-preserving surgery. Patients with permanent stoma creation had a shorter tumour distance from the anal verge (P < 0.001), larger tumour size (P = 0.020) and higher preoperative Faecal Incontinence Severity Index score (P = 0.020). On multivariable analysis, tumour distance from the anal verge predicted permanent stoma formation (relative risk 0.53 per centimetre increase; 95% confidence interval 0.46-0.60; P < 0.001) but preoperative anal function did not. CONCLUSION: Tumour distance from the anal verge was the only preoperative determinant of permanent stoma creation in rectal cancer patients. These data may help mid and low rectal cancer patients understand the need for permanent stoma.


Subject(s)
Rectal Neoplasms , Surgical Stomas , Anal Canal/surgery , Cohort Studies , Humans , Ileostomy , Rectal Neoplasms/surgery
2.
Colorectal Dis ; 21(10): 1175-1182, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31124259

ABSTRACT

AIM: This study aimed to investigate the association between Twitter exposure and the number of citations for coloproctology articles. METHOD: Original articles from journals using Twitter between June 2015 and May 2016 were evaluated for the following characteristics: publishing journal; article subject; study design; nationality, speciality and affiliation of the author(s); and reference on Twitter. Citation data for these articles were retrieved from Google Scholar (https://scholar.google.com) in January 2018. We performed a univariate analysis using these data followed by a multivariate, logistic regression analysis to search for factors associated with a high citation level, which was defined as accrual of more than five citations. RESULTS: Out of six coloproctology journals listed on the InCites JCR database, three (Diseases of the Colon & Rectum, Colorectal Disease and Techniques in Coloproctology) used Twitter, where 200 (49.5%) out of a total of 404 articles had been featured. Citation rates of articles that featured on Twitter were significantly higher than those that did not (11.4 ± 9.2 vs 4.1 ± 3.1, P < 0.001). In multivariate analysis, Twitter exposure (OR 8.6, P = 0.001), European Union nationality (OR 2.4, P = 0.004), Colorectal Disease journal (OR 3.3, P = 0.005) and systematic review articles (OR 3.4, P = 0.009) were associated with higher citation levels. CONCLUSION: Article exposure on Twitter was strongly associated with a high citation level. Medical communities should encourage journals as well as physicians to actively utilize social media to expedite the spread of new ideas and ultimately benefit medical society as a whole.


Subject(s)
Colorectal Surgery/statistics & numerical data , Journal Impact Factor , Social Media/statistics & numerical data , Humans , Multivariate Analysis
3.
Colorectal Dis ; 21(1): 38-47, 2019 01.
Article in English | MEDLINE | ID: mdl-30047583

ABSTRACT

AIM: We aimed to isolate and propagate internal and external anal sphincter progenitor cells from the human anal sphincter, with or without radiotherapy, for tailored cell therapy of faecal incontinence. METHODS: Sphincter progenitor cells were isolated from normal internal and external anal sphincters collected from 10 patients with rectal cancer who had undergone abdominoperineal resection with (n = 6) or without (n = 4) preoperative chemoradiotherapy. The isolated cells and differentiated muscle fibres were identified using immunofluorescence assay, western blotting and reverse transcription polymerase chain reaction (RT-PCR). The proliferation of progenitor cells with and without radiotherapy was compared by quantitative 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. RESULTS: The immunofluorescence assay before differentiation confirmed that the internal anal sphincter progenitor cells expressed CD34 and neural-glial antigen 2 (NG2), whereas the external anal sphincter progenitor cells expressed CD34 and PAX7. After differentiation, the internal anal sphincter progenitor cells expressed desmin, calponin and α-smooth muscle actin, whereas the external anal sphincter progenitor cells expressed desmin, myogenic factor 4 and myosin heavy chain. The differential expression profiles of both cell types were confirmed by western blotting and RT-PCR. MTT assays showed that the viability of internal and external anal sphincter progenitor cells was significantly lower in the radiotherapy group than that in the nonradiotherapy group. CONCLUSIONS: This study describes the differential harvest internal and external sphincter muscle progenitor cells from human anal sphincters. We confirm that radiotherapy decreases the viability of internal and external anal sphincter progenitor cells.


Subject(s)
Anal Canal/cytology , Cell Proliferation , Cell Survival , Chemoradiotherapy , Muscle Fibers, Skeletal/cytology , Myocytes, Smooth Muscle/cytology , Rectal Neoplasms/therapy , Stem Cells/cytology , Actins/metabolism , Aged , Aged, 80 and over , Anal Canal/metabolism , Antigens/metabolism , Antigens, CD34/metabolism , Calcium-Binding Proteins/metabolism , Case-Control Studies , Cell- and Tissue-Based Therapy , Desmin/metabolism , Fecal Incontinence/therapy , Female , Humans , Male , Microfilament Proteins/metabolism , Middle Aged , Muscle Fibers, Skeletal/metabolism , Myocytes, Smooth Muscle/metabolism , Myogenin/metabolism , Myosin Heavy Chains/metabolism , Neoadjuvant Therapy , PAX7 Transcription Factor/metabolism , Proctectomy , Proteoglycans/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Stem Cells/metabolism , Calponins
4.
Anaesthesia ; 73(9): 1090-1096, 2018 Sep.
Article in English | MEDLINE | ID: mdl-29727028

ABSTRACT

There have been few objective evaluations of the effects of deep neuromuscular blockade on intra-operative conditions. In this prospective randomised controlled study, we evaluated the effects of deep neuromuscular block on surgical conditions during laparoscopic colorectal surgery. Patients were randomly allocated using a computer-generated randomisation code to either moderate (train-of-four count 1-2 maintained and antagonised with neostigmine) or deep (post-tetanic count 1-2 maintained and reversed with sugammadex) levels of neuromuscular blockade. The primary outcome measure was the number of abrupt increases in intra-abdominal pressure intra-operatively. Secondary outcome variables were intra-operative restoration of spontaneous breathing, number of surgical requests for additional neuromuscular blockade, surgical rating of operating conditions and patient satisfaction. The surgeon who rated the surgical conditions score and investigator who checked the postoperative variables were blinded to patient allocation. In total, we recruited 70 patients of whom 64 (32 in each group) were analysed. Increases in intra-abdominal pressure (14/32 vs. 6/32; p = 0.031), intra-operative restoration of spontaneous breathing (16/32 vs. 2/32; p < 0.001) and request for additional neuromuscular blockade (21/32 vs. 8/32; p = 0.001) were more frequent in the moderate compared with the deep group. In patients undergoing elective laparoscopic colorectal surgery, deep neuromuscular blockade provided better surgical conditions than moderate neuromuscular blockade, as measured by a reduction in the incidence of intra-abdominal pressure alarms.


Subject(s)
Colorectal Neoplasms/surgery , Laparoscopy/methods , Neuromuscular Blockade/methods , Adult , Aged , Double-Blind Method , Drug Administration Schedule , Female , Humans , Intraoperative Period , Male , Middle Aged , Monitoring, Intraoperative/methods , Neuromuscular Nondepolarizing Agents/administration & dosage , Patient Satisfaction , Pneumoperitoneum, Artificial , Prospective Studies , Rocuronium/administration & dosage , Young Adult
5.
Curr Mol Med ; 16(9): 829-839, 2016.
Article in English | MEDLINE | ID: mdl-27889996

ABSTRACT

PURPOSE: Recently, a different type of microsatellite instability (MSI) instability designated 'elevated microsatellite alterations at selected tetranucleotide repeats' (EMAST) has been reported in several neoplasms, but its clinical implications remain unclear. We aimed to determine the relationships among EMAST, MSI and clinicopathologic characteristics, including oncologic outcomes, in colorectal cancer (CRC). MATERIALS AND METHODS: We evaluated 100 sporadic CRC cases subjected to surgery using five markers (MYCL1, D9S242, D20S85, D8S321, and D20S82) for EMAST and the Bethesda panel for MSI status. Immunohistochemical detection of hMSH3, c-erbB2, EGFR and thymidylate synthase was performed. Clinical characteristics and prognostic relevance were assessed. RESULTS: We identified 22 EMAST-positive tumors (22.0%) and 32 MSI-high (MSI-H) tumors (32.0%). EMAST was more frequent in colon cancer than rectal cancer (p=0.033), and associated with MSI-H phenotype (p<0.001), low expression of hMSH3 (p=0.004), and overexpression of thymidylate synthase (p=0.006). Among the 38 MSI-L tumors, only one (4.5%) showed EMAST. Long-term oncologic results in terms of overall and disease-free survival were similar between EMAST and non-EMAST tumors. CONCLUSION: EMAST is more closely related to MSI-H than MSI-L or MSS status. The clinical and molecular characteristics of EMAST were distinct in terms of tumor location, thymidylate synthase expression, MSI status and hMSH3 expression. Our preliminary findings support the utility of EMAST as a new potential classifier in CRC.


Subject(s)
Colorectal Neoplasms/genetics , Colorectal Neoplasms/pathology , Microsatellite Repeats/genetics , Aged , Biomarkers, Tumor/genetics , Colorectal Neoplasms/mortality , Disease-Free Survival , Female , Humans , Male , Microsatellite Instability , Phenotype , Prognosis
6.
Scand J Med Sci Sports ; 26(5): 572-8, 2016 May.
Article in English | MEDLINE | ID: mdl-25996828

ABSTRACT

The purpose of this study is to investigate abnormal magnetic resonance image (MRI) findings of young active males with atraumatic anterior knee pain (AKP). Targeting young male soldiers, we prospectively gathered and analyzed 157 knee MRIs from patients with atraumatic AKP (AKP group) and 53 knee MRIs from patients without knee pain (control group). Abnormalities of the patellofemoral (PF) joint and extensor mechanism on MRI were more common in the AKP group than the control group (48% vs 13%, P < 0.001). The overall prevalence of medial plica (34% vs 13%, P = 0.004) and the prevalence of the thick medial plica (9% vs 0%, P = 0.023) were considerably higher in the AKP group. The cartilaginous sulcus angle in the AKP group without abnormalities on MRI was significantly higher than both the AKP group with abnormalities and the control group (145° vs 141° vs 142°, respectively, P = 0.001). Our results suggest that careful assessment of young, active males with atraumatic AKP is warranted regarding PF joint abnormalities, particularly the presence of medial plica and/or subtle abnormalities of the articular geometry. The results from the present study could be used for the management of patients with AKP.


Subject(s)
Arthralgia/diagnostic imaging , Arthralgia/etiology , Military Personnel , Patellofemoral Joint/diagnostic imaging , Synovial Membrane/diagnostic imaging , Adult , Cartilage, Articular/diagnostic imaging , Case-Control Studies , Humans , Magnetic Resonance Imaging , Male , Prospective Studies , Republic of Korea , Tendons/diagnostic imaging , Young Adult
8.
Eur J Surg Oncol ; 41(4): 585-91, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25624160

ABSTRACT

AIM: The aim of this study was to evaluate the effects of adherence to National Comprehensive Cancer Network (NCCN) guidelines on survival outcomes in patients with early-stage epithelial ovarian cancer. METHODS: Our institutional cancer registry data on 266 patients with Stage I epithelial ovarian cancer was reviewed retrospectively and compliance with treatment guidelines for surgery and adjuvant treatment was determined. Patients were categorized according to adherence or non-adherence. The primary endpoints were recurrence-free survival and disease-specific survival. Hazard ratios (HRs) for survival were estimated with a Cox proportional hazards model. RESULTS: Of the 266 patients, 71 (26.7%) underwent adequate surgical staging in accordance with the guidelines. The guidelines for adjuvant chemotherapy were followed adequately in all 71 patients that were adherent to surgical staging and in 163 of the 195 patients with non-adherence to surgical staging (83.6%). Multivariate analysis, adjusted for prognostic factors, identified higher recurrence-free survival (HR, 0.36; 95% CI, 0.15-0.88) and disease-specific survival (HR, 0.42; 95% CI, 0.16-1.12) among patients whose treatment adhered to both surgical and chemotherapy guidelines, although disease-specific survival was not statistically significant. When excluding clear cell histology from the cohort, the guideline-adherent group had significantly better disease-specific survival than the non-adherent group (HR, 0.13; 95% CI, 0.02-0.94). CONCLUSION: The results of this study suggest that adherence to NCCN guidelines may improve survival outcomes in patients with early-stage epithelial ovarian cancer, particularly in cases other than clear cell histology.


Subject(s)
Adenocarcinoma, Clear Cell/pathology , Adenocarcinoma, Clear Cell/surgery , Guideline Adherence , Lymph Node Excision , Neoplasms, Glandular and Epithelial/pathology , Neoplasms, Glandular and Epithelial/surgery , Ovarian Neoplasms/pathology , Ovarian Neoplasms/surgery , Adenocarcinoma, Clear Cell/drug therapy , Adolescent , Adult , Aged , Aged, 80 and over , Antineoplastic Agents/therapeutic use , Aorta , Carcinoma, Ovarian Epithelial , Chemotherapy, Adjuvant , Disease-Free Survival , Female , Humans , Hysterectomy , Middle Aged , Neoplasm Grading , Neoplasm Staging , Neoplasms, Glandular and Epithelial/drug therapy , Ovarian Neoplasms/drug therapy , Ovariectomy , Peritoneal Lavage , Practice Guidelines as Topic , Retrospective Studies , Salpingectomy , Survival Rate , Young Adult
9.
Osteoarthritis Cartilage ; 23(2): 232-8, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25450843

ABSTRACT

OBJECTIVE: We sought to determine (1) whether change in the tibial plateau inclination (TPI) after high tibial osteotomy (HTO) is different from change in the knee joint line orientation (KJLO) relative to the ground; (2) whether, in varus knee OA patients before and after HTO, these radiographic measures are different from those in normal control; and (3) whether the postoperative values of the TPI and KJLO relative to the ground are associated with short term clinical outcome scores after HTO. DESIGN: Fifty patients who underwent HTO and 75 normal controls were assessed with four radiographic measures. We compared the measures before HTO with those after HTO and with those of the normal controls, then examined associations between the postoperative radiographic measures and clinical outcome scores 1-year after HTO. RESULTS: After HTO, TPI increased 9.0°, whereas KJLO relative to the ground only increased 4.1°, with a compensatory change of the ankle joint line orientation. However, the postoperative KJLO relative to the ground in the HTO group was significantly different from that of the normal controls (mean difference, 4.9°; P < 0.001). In the multiple regression analyses, the postoperative radiographic measures were not associated with outcome clinical scores 1 year after HTO. CONCLUSION: After HTO the relative KJLO changed significantly less than did the anatomical geometry of the proximal tibia. Although the KJLO after the HTO was still significantly different from that of normal knees, its value did not adversely affect clinical outcome scores 1 year after HTO.


Subject(s)
Ankle Joint/anatomy & histology , Knee Joint/anatomy & histology , Osteoarthritis, Knee/surgery , Osteotomy , Tibia/surgery , Adult , Female , Humans , Male , Middle Aged , Osteotomy/methods , Postoperative Period
10.
Cytopathology ; 26(1): 19-25, 2015 Feb.
Article in English | MEDLINE | ID: mdl-24766438

ABSTRACT

OBJECTIVES: This study was performed to evaluate the prognostic significance of human papillomavirus (HPV) viral load, expressed in relative light units (RLUs), in patients with atypical squamous cells of undetermined significance (ASC-US) cytology. METHODS: A total of 349 ASC-US cases with HPV infection, detected using Hybrid Capture 2, were diagnosed histologically. A colposcopically directed punch biopsy was performed on acetowhite areas. Endocervical curettage biopsy and random cervical punch biopsy in four quadrants were performed in unsatisfactory colposcopy cases. In negative colposcopy cases, random cervical punch biopsy in four quadrants was performed. RESULTS: Case with no cervical intraepithelial neoplasia (CIN), CIN1 and CIN2+ (CIN2/CIN3) accounted for 162, 135 and 52 cases, respectively. The mean age showed no difference among the three groups (P = 0.510). There was a significant correlation between RLU values and the presence of CIN (P < 0.001), but less so with its severity: the median RLU values for negative, CIN1 and CIN2+ cases were 42.68, 146.45 and 156.43, respectively, with widely overlapping confidence intervals. The cut-off values of RLU to detect CIN1+ and CIN2+ were 6.73 and 45.64, respectively. CONCLUSIONS: The HPV viral load in ASC-US cases showed a significant correlation with the presence of CIN and less so with its severity, and showed large overlap of viral loads between grades of CIN. In ASC-US cases, RLU was not an accurate predictor of immediate high-grade CIN.


Subject(s)
Atypical Squamous Cells of the Cervix , Uterine Cervical Dysplasia/diagnosis , Viral Load , Adult , Colposcopy , Cytodiagnosis , Female , Humans , Middle Aged , Neoplasm Staging , Papillomaviridae/pathogenicity , Papillomavirus Infections/diagnosis , Papillomavirus Infections/pathology , Papillomavirus Infections/virology , Pregnancy , Prognosis , Uterine Cervical Dysplasia/pathology , Uterine Cervical Dysplasia/virology
11.
Anaesthesia ; 69(12): 1314-21, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25132158

ABSTRACT

We investigated the effects of magnesium sulphate on blood coagulation profiles using rotational thromboelastometry in patients undergoing laparoscopic colorectal cancer surgery. Patients were randomly allocated to the magnesium group (n = 22) or control group (n = 22). The magnesium group received intravenous magnesium sulphate (50 mg.kg(-1) followed by a continuous infusion of 15 mg.kg(-1) .h(-1) ), whereas the control group received the same volume of isotonic saline. Mean (SD) postoperative serum magnesium levels were 1.60 (0.13) mmol.l(-1) in the magnesium group compared with 0.98 (0.06) mmol.l(-1) in the control group (p < 0.001). All maximum clot firmness values of ROTEM analysis were significantly lower on the third postoperative day in the magnesium group compared with the control group (p < 0.05). We conclude that ROTEM analysis demonstrated that intra-operative administration of intravenous magnesium sulphate reduces blood hypercoagulability in patients undergoing laparoscopic colorectal cancer surgery.


Subject(s)
Colorectal Neoplasms/surgery , Laparoscopy , Magnesium Sulfate/therapeutic use , Postoperative Complications/prevention & control , Thrombelastography/methods , Thrombophilia/prevention & control , Aged , Double-Blind Method , Female , Humans , Magnesium/blood , Male , Middle Aged
12.
Technol Cancer Res Treat ; 12(1): 45-51, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22905806

ABSTRACT

The purpose of this study was to evaluate whether bulky lymphadenopathy located in the abdominopelvic cavity in cervical cancer can be controlled without severe toxicity by increasing radiation dose using helical tomotherapy. From January 2007 to December 2010, 26 patients with cervical cancer with metastatic lymph nodes (LNs) having at least one short diameter > 1.5 cm were treated with helical tomotherapy. A total of 58 LN sites were treated and the largest LN of each site was evaluated for response. Median follow-up time was 28 months (4-50 months). Median short diameter of the LNs was 1.7 cm (0.7-4.2 cm) with median radiation dose of 62.6 Gy(10) in 2 Gy equivalent dose (53.3-77.9 Gy(10)). Initial LN response was evaluated on imaging obtained within 4 months after radiotherapy. Initial complete response (CR), partial response (PR), and stable disease (SD) were observed in 54, 2 and 2 lesions, respectively. Recurrence occurred in two with CR and progression in one with PR. Therefore, final CR, PR, SD, and progression of disease were observed in 52, 1, 2, and 3, respectively. Actuarial 3-year LN progression-free survival and overall survival (OS) were 63% and 65%, respectively. Multivariate analysis revealed final LN response (CR vs. non-CR) as a strong prognostic factor for OS (p = 0.016). Radiation Therapy Oncology Group grade 2 or more acute and late toxicity was observed in 8 and 1 patients, respectively. The treatment of bulky lymphadenopathy using helical tomotherapy in advanced cervical cancer is highly effective and has acceptable toxicity.


Subject(s)
Lymph Nodes/pathology , Radiotherapy, Intensity-Modulated , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/radiotherapy , Adult , Aged , Disease Progression , Female , Humans , Middle Aged , Neoplasm Staging , Radiotherapy Dosage , Radiotherapy Planning, Computer-Assisted , Radiotherapy, Intensity-Modulated/adverse effects , Rectum/radiation effects , Treatment Outcome , Urinary Bladder/radiation effects , Uterine Cervical Neoplasms/mortality
13.
Eur J Gynaecol Oncol ; 34(6): 513-7, 2013.
Article in English | MEDLINE | ID: mdl-24601041

ABSTRACT

PURPOSE: To investigate the attitudes of Korean gynecologists towards prescribing hormone replacement therapy (HRT) after treatment for endometrial cancer. MATERIALS AND METHODS: A questionnaire, addressing attitudes towards HRT and treatment strategies for patients previously treated for endometrial cancer, was distributed to 163 Korean gynecologists. RESULTS: Of the 163 gynecologists that were sent this questionnaire, 98 (60.1%) responded. Among the respondents, 81 (82.7%) had previously prescribed HRT to patients with endometrial cancer. Of the latter, 75 (92.6%) had prescribed HRT to patients with Stage I, and more than half to patients with Stage II, endometrial cancer. Of the respondents who had prescribed HRT, 33 (40.7%) did so without regard for cancer-cell type and 33 (40.7%) began patients on HRT more than two years after endometrial cancer treatment. Tibolone was the most commonly prescribed drug (61.9%). The most common reason not to prescribe HRT was fear of cancer recurrence (38.1%). CONCLUSION: Most of the Korean gynecologists surveyed had experience prescribing HRT to endometrial cancer patients. Although HRT is not actively recommended, HRT given post-therapy to endometrial cancer patients is considered acceptable.


Subject(s)
Adenocarcinoma/pathology , Attitude of Health Personnel , Endometrial Neoplasms/pathology , Estrogen Receptor Modulators/therapeutic use , Gynecology , Hormone Replacement Therapy , Norpregnenes/therapeutic use , Adenocarcinoma/surgery , Adult , Endometrial Neoplasms/surgery , Female , Hormone Replacement Therapy/adverse effects , Humans , Hysterectomy/adverse effects , Male , Menopause, Premature , Middle Aged , Neoplasm Grading , Neoplasm Staging , Ovariectomy/adverse effects , Practice Patterns, Physicians' , Republic of Korea , Salpingectomy/adverse effects , Surveys and Questionnaires , Time Factors
14.
Ann Oncol ; 23(4): 911-8, 2012 Apr.
Article in English | MEDLINE | ID: mdl-21821549

ABSTRACT

BACKGROUND: This study was conducted to analyze the feasibility of adjuvant capecitabine therapy using a tailored-dose escalation strategy in elderly patients with colon cancer (CC). METHODS: CC patients (≥ 70 years of age) who received adjuvant capecitabine were enrolled. The starting dosage of capecitabine was 2000 mg/m(2)/day (days 1-14, every 3 weeks). On the second cycle, the dosage was escalated to 2500 mg/m(2)/day if the patient tolerated the first cycle. Dose intensity (DI), toxicity, and the change in quality of life (QoL) were evaluated. RESULTS: Of 82 patients enrolled, 67 completed eight cycles. Dose escalation to 2500 mg/m(2)/day was possible in 56 patients, and this dosage was maintained in 24 patients until the completion of chemotherapy (eight cycles). Forty-one patients completed therapy with a DI ≥ 1333 mg/m(2)/day [relative dose intensity (RDI) ≥ 80%]. Toxic effects were tolerable and the QoL was not compromised during treatment. Creatinine clearance < 50 ml/min and Charlson-Age comorbidity index ≥ 8 were related to a reduced capecitabine dosage (RDI < 80%). CONCLUSIONS: A tailored-dose escalation strategy was feasible in elderly CC patients receiving adjuvant capecitabine chemotherapy. Decreased renal function and an increased number of comorbidities were independently predictive of reduced administration of the capecitabine dose.


Subject(s)
Adenocarcinoma/drug therapy , Antimetabolites, Antineoplastic/therapeutic use , Colonic Neoplasms/drug therapy , Deoxycytidine/analogs & derivatives , Fluorouracil/analogs & derivatives , Adenocarcinoma/mortality , Aged , Aged, 80 and over , Capecitabine , Chemotherapy, Adjuvant , Colonic Neoplasms/mortality , Deoxycytidine/therapeutic use , Disease-Free Survival , Drug Dosage Calculations , Female , Fluorouracil/therapeutic use , Humans , Kaplan-Meier Estimate , Male , Multivariate Analysis , Quality of Life , Treatment Outcome
15.
Endoscopy ; 43(6): 526-32, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21425040

ABSTRACT

BACKGROUND AND STUDY AIMS: Several reports have demonstrated the safety of pure natural-orifice transluminal endoscopic surgery (P-NOTES) using transanal endoscopic microsurgery (TEM) and embryonic NOTES (E-NOTES; laparoscopic surgery through the umbilicus). This study was performed to compare the safety and applicability of NOTES rectosigmoidectomy between E-NOTES and P-NOTES in a swine model. PATIENTS AND METHODS: E-NOTES was conducted through a single port using laparoscopic instruments (n = 11). P-NOTES was performed using TEM with transgastric endoscopic assistance (n = 11). Gastrotomies were created using a needle knife and the balloon dilatation technique, and closed using T-anchors. Blood samples were collected to evaluate changes in systemic cytokine levels during the preoperative and postoperative periods; operative outcomes were also evaluated and compared between the groups. The necropsy findings were recorded after sacrifice at 1 week after the procedure. RESULTS: The mean operative time for P-NOTES was significantly longer than that for E-NOTES (239 vs. 103 minutes, P < 0.001). The mean distance from the anal verge to colorectal anastomosis in the P-NOTES group was significantly less than that in the E-NOTES group (2.9 vs. 17.6 cm, P < 0.001). On necropsy, the complication rate of P-NOTES was higher than that of E-NOTES, but without statistical significance (54.5 % vs. 18.2 %, P = 0.091). The differences in changes in TNF-α, C-reactive protein, interleukin-6, and interleukin-1ß between P-NOTES and E-NOTES were not significant. CONCLUSIONS: E-NOTES rectosigmoidectomy in the swine model is safe, but remains challenging for use in pelvic dissection. P-NOTES rectosigmoidectomy using TEM may be a promising tool for pelvic dissection, but the transgastric approach involves a high degree of risk.


Subject(s)
Colectomy/methods , Hematoma/etiology , Natural Orifice Endoscopic Surgery/methods , Peritoneal Diseases/etiology , Abdominal Abscess/etiology , Anal Canal , Animals , Ascites/etiology , C-Reactive Protein/metabolism , Colectomy/adverse effects , Interleukin-1beta/blood , Interleukin-6/blood , Laparoscopy , Male , Models, Animal , Natural Orifice Endoscopic Surgery/adverse effects , Surgical Wound Infection/etiology , Swine , Time Factors , Tissue Adhesions/etiology , Tumor Necrosis Factor-alpha/blood , Umbilicus
16.
Eur J Surg Oncol ; 36(7): 691-8, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20570475

ABSTRACT

BACKGROUND: Uterine sarcomas are rare among all uterine malignancies, and frequently misdiagnosed as benign uterine diseases such as leiomyoma and adenomyosis because of lack of feasible tools for the preoperative diagnosis. Although some studies have suggested the role of serum CA-125 levels for the preoperative diagnosis, the efficacy is controversial. Since malignancy is known to be associated with systemic inflammation which leads to hematological alteration, we compared the efficacy for the preoperative diagnosis of uterine sarcomas between the neutrophil to lymphocyte ratio (NLR) and serum CA-125 levels using a case-match comparison. METHODS: From November 2004 to December 2008, 55 patients with carcinosarcoma (n=21), leiomyosarcoma (n=20) and endometrial stromal sarcoma (n=14) were matched to 330 patients with leiomyoma (n=165) and adenomyosis (n=165) in terms of age at diagnosis, body mass index and uterine volume. RESULTS: The receiver operating characteristic curve showed the best cut-off values of the NLR (>or=2.12) and serum CA-125 levels (>or=27.5U/ml) for the preoperative diagnosis of uterine sarcomas, demonstrating that the NLR was more powerful for the preoperative diagnosis of uterine sarcomas than serum CA-125 levels (sensitivity, 74.5% vs. 52.3%; specificity, 70.3% vs. 50.5%; positive predictive value, 29.5% vs. 15.1%; negative predictive value, 94.3% vs. 86.5%; accuracy, 60.6% vs. 49.6%; p<0.05). Furthermore, the NLR reflected recurrence and progression more accurately than serum CA-125 levels in patients with uterine sarcomas. CONCLUSIONS: These findings suggest that the NLR may be more useful than serum CA-125 levels as a cost-effective tool for the preoperative diagnosis in patients with uterine sarcomas.


Subject(s)
Biomarkers, Tumor/blood , Lymphocytes , Neutrophils , Sarcoma/blood , Sarcoma/diagnosis , Uterine Neoplasms/blood , Uterine Neoplasms/diagnosis , Adult , Aged , Aged, 80 and over , CA-125 Antigen/blood , Carcinosarcoma/blood , Carcinosarcoma/diagnosis , Case-Control Studies , Endometriosis/blood , Endometriosis/diagnosis , Female , Humans , Leiomyoma/blood , Leiomyoma/diagnosis , Leiomyosarcoma/blood , Leiomyosarcoma/diagnosis , Middle Aged , Population Surveillance , Predictive Value of Tests , ROC Curve , Research Design , Retrospective Studies , Sample Size , Sarcoma/immunology , Sarcoma/pathology , Sarcoma/surgery , Sarcoma, Endometrial Stromal/blood , Sarcoma, Endometrial Stromal/diagnosis , Sensitivity and Specificity , Uterine Neoplasms/immunology , Uterine Neoplasms/pathology , Uterine Neoplasms/surgery
17.
Eur J Surg Oncol ; 35(9): 969-73, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19324510

ABSTRACT

AIMS: The purpose of this study was to examine the clinical impact of under-diagnosis by frozen section examination in borderline ovarian tumors (BOTs). METHODS: We reviewed 209 consecutive patients with BOTs who were diagnosed and treated at our institute between March 1988 and July 2007. Tumors from 182 of 209 patients were evaluated by frozen section examination. After excluding a case with a deferred diagnosis, the results of frozen section examinations were compared with the final paraffin section examination. In 61 patients, the frozen section examination under-diagnosed a BOT as a benign tumor. In 120 patients, the frozen section examination correctly diagnosed or over-diagnosed a BOT. The clinical impact of under-diagnosis was evaluated by comparing the extent of surgery and treatment outcome between the patients who were under-diagnosed (study group) and the patients who were not under-diagnosed (control group). RESULTS: The study group had more mucinous (P=0.03) and/or stage 1A (P=0.02) tumors than the control group. Fewer patients in the study group received adjuvant chemotherapy than the patients in the control group (P=0.02). Fewer patients in the study group underwent radical surgery than the patients in the control group (P=0.02). However, the rates of treatment failure were similar between the two groups (no treatment failure in the study group and seven treatment failures in the control group; P=0.10). CONCLUSIONS: The under-diagnosis by frozen section examination did not compromise the outcome in patients with BOTs, although under-diagnosis was associated with more conservative surgery.


Subject(s)
Biopsy/methods , Diagnostic Errors , Frozen Sections , Ovarian Neoplasms/pathology , Adult , Aged , Case-Control Studies , False Negative Reactions , Female , Humans , Korea , Middle Aged , Ovarian Neoplasms/surgery , Retrospective Studies , Treatment Outcome
18.
Ann Oncol ; 20(6): 1032-6, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19193704

ABSTRACT

BACKGROUND: This study was to investigate the prognostic significance of clinicopathologic characteristics in patients with clear-cell carcinoma (CCC) of the ovary. MATERIALS AND METHODS: Two hundred and one patients with CCC of the ovary were registered in the Korean Gynecologic Oncology Group. The Korean Gynecologic Pathology Study Group reviewed the pathological slides centrally, using a universal grading system. The prognostic significances of clinicopathologic factors were evaluated by multivariate analysis. RESULTS: Most of the patients were diagnosed at an early stage (stage I, 61.3%), and the overall 5-year survival rate was 57%. Early-stage disease showed a favorable prognosis, but advanced diseases showed poor prognosis. Stage of disease was the only significant prognostic factor on multivariate analysis (P < 0.001). However, universal grade and residual tumor also showed prognostic significance on the forward stepwise likelihood ratio test. There was no survival difference observed between patients treated with paclitaxel-based and those treated with platinum-based combination chemotherapy. CONCLUSIONS: The stage, residual tumor, and universal grade were significant prognostic factors in patients with CCC of the ovary. The universal grading system is applicable in determining prognosis of CCC of the ovary. Further clinical trials for optimal chemotherapy are in need.


Subject(s)
Adenocarcinoma, Clear Cell/pathology , Ovarian Neoplasms/pathology , Registries , Adenocarcinoma, Clear Cell/drug therapy , Adenocarcinoma, Clear Cell/surgery , Adult , Aged , Antineoplastic Agents/therapeutic use , Female , Humans , Korea , Middle Aged , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/surgery , Prognosis , Retrospective Studies
19.
Eur J Surg Oncol ; 35(8): 870-6, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19179039

ABSTRACT

BACKGROUND: We sought to identify the role of serum CA-125 levels in early-stage epithelial ovarian cancer (EOC) on preoperative CT and MRI. METHODS: Clinical data of 101 patients with early-stage EOC on preoperative CT and MRI were collected between January 2000 and December 2007. Clinical stage I (n=59) was defined as tumor limited to the ovaries with or without ascites, whereas clinical stage II (n=42) was defined as tumor within the pelvis with or without ascites. The primary endpoint was to investigate the efficacy of serum CA-125 levels for the prediction of advanced-stage disease, and secondary endpoints were to evaluate the accuracy of preoperative CT and MRI, and to examine the role of serum CA-125 levels as a prognostic factor for survival. RESULTS: The results of preoperative CT and MRI were concordant with no peritoneal implants outside the pelvis in 50/101 (50%) and no lymph node metastasis in 71/101 (70%) patients. The receiver operating characteristic curves showed that best cut-off values of serum CA-125 levels were 320 U/ml (71% sensitivity, 84% specificity) and 510 U/ml (67% sensitivity, 80% specificity) for the prediction of peritoneal implants outside the pelvis and lymph node metastasis. The serum CA-125 level (> or =320 U/ml) was a significant factor for the prediction of advanced-stage disease (adjusted OR, 7.43; 95% CI, 2.39-23.04). However, it was not an independent prognostic factor for survival. CONCLUSIONS: Serum CA-125 levels may be very useful for the prediction of advanced-stage disease in early-stage EOC on preoperative CT and MRI.


Subject(s)
Adenocarcinoma/blood , CA-125 Antigen/blood , Ovarian Neoplasms/blood , Adenocarcinoma/diagnosis , Adenocarcinoma/pathology , Adult , Aged , Antineoplastic Agents/administration & dosage , Female , Humans , Magnetic Resonance Imaging , Middle Aged , Neoplasm Staging , Ovarian Neoplasms/diagnosis , Ovarian Neoplasms/pathology , Predictive Value of Tests , Prognosis , Retrospective Studies , Survival Analysis , Tomography, X-Ray Computed
20.
Eur J Surg Oncol ; 35(2): 192-6, 2009 Feb.
Article in English | MEDLINE | ID: mdl-18490129

ABSTRACT

AIMS: In cervical cancer patients with intermediate-risk factors, the optimal adjuvant therapy is still controversial. We retrospectively compared the treatment outcome of chemoradiation with that of radiation. METHODS: From 1997 to 2005, 79 consecutive cervical cancer patients received postoperative adjuvant therapy indicated by intermediate-risk factors. Fifty-five women received chemoradiation and 24 women received radiation. Risk factors, recurrence-free survival (RFS), adverse events, and recurrence pattern were investigated and were compared between the chemoradiation and radiation groups. RFS was calculated by the Kaplan-Meier method and was compared by the log-rank test. RESULTS: Risk factors were well-balanced between the two groups. Four patients recurred in the chemoradiation group and eight patients recurred in the radiation group. RFS rate of the chemoradiation group was significantly higher than that of the radiation group (P=0.01). Hematologic toxicity was more common in the chemoradiation group than in the radiation group (P<0.01). However, non-hematologic toxicity was similar between the two groups and most of the patients (97%) completed postoperative adjuvant therapy. Recurrence pattern was similar between the two groups. CONCLUSION: In cervical cancer patients with intermediate-risk factors, chemoradiation was well-tolerated and more effective than radiation as a postoperative adjuvant therapy.


Subject(s)
Antineoplastic Agents/therapeutic use , Postoperative Care/methods , Uterine Cervical Neoplasms/radiotherapy , Disease-Free Survival , Female , Follow-Up Studies , Gynecologic Surgical Procedures , Humans , Incidence , Middle Aged , Neoplasm Recurrence, Local/epidemiology , Radiotherapy, Adjuvant/methods , Retrospective Studies , Risk Factors , Time Factors , Treatment Outcome , Uterine Cervical Neoplasms/drug therapy , Uterine Cervical Neoplasms/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...